Iranian Journal of Pediatrics

Published by: Kowsar

Chemotherapy-Induced Peripheral Neuropathy in a Subpopulation of Mexican Pediatric Patients with Acute Lymphoblastic Leukemia

Irving Jesus Vivas-Rosales 1 , Liliana Garcia-Saavedra 2 , Jorge Alfonso Martin-Trejo 3 , Juan Manuel Mejia-Arangure 4 , Nora Patricia Victorio-Garcia 5 , Alejandro Herrera-Landero 6 and Juan Carlos Núñez-Enríquez 7 , *
Authors Information
1 Department of Pediatric, Pediatrics Hospital, National Medical Center (The Siglo XXI), Mexican Institute of Social Security
2 Department of Physical Medicine and Rehabilitation, Pediatrics Hospital, National Medical Center (The Siglo XXI), Mexican Institute of Social Security
3 Department of Hematology, Pediatrics Hospital, National Medical Center (The Siglo XXI), Mexican Institute of Social Security
4 Division of Evaluation of Research, Health Research Coordination, Mexican Institute of Social Security
5 Faculty of Medicine of Tampico “Dr. Alberto Romo Caballero”, Autonomous University of Tamaulipas
6 Traumatology and Orthopedics Hospital “Lomas Verdes” Mexican Institute of Social Security
7 Clinical Epidemiology Research Department, Pediatrics Hospital, National Medical Center (The Siglo XXI), Mexican Institute of Social Security
Article information
  • Iranian Journal of Pediatrics: October 2017, 27 (5); e11844
  • Published Online: October 22, 2017
  • Article Type: Research Article
  • Received: April 18, 2017
  • Revised: June 24, 2017
  • Accepted: July 20, 2017
  • DOI: 10.5812/ijp.11844

To Cite: Vivas-Rosales I J, Garcia-Saavedra L, Martin-Trejo J A, Mejia-Arangure J M, Victorio-Garcia N P, et al. Chemotherapy-Induced Peripheral Neuropathy in a Subpopulation of Mexican Pediatric Patients with Acute Lymphoblastic Leukemia, Iran J Pediatr. 2017 ; 27(5):e11844. doi: 10.5812/ijp.11844.

Copyright © 2017, Iranian Journal of Pediatrics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Fajardo-Gutierrez A, Mejía-Aranguré M, Gómez-Delgado A. Epidemiología de las neoplasias malignas en ni-os residentes del Distrito Federal (1982-1991) [In Spanish]. Bol Med Hosp Infant Mex. 1995; 52: 507-16
  • 2. Fajardo-Gutierrez A, Mejia-Arangure JM, Hernandez-Cruz L, Mendoza-Sanchez HF, Garduno-Espinosa J, Martinez-Garcia MC. [Descriptive epidemiology of malignant tumors in children]. Rev Panam Salud Publica. 1999; 6(2): 75-88[PubMed]
  • 3. Armstrong T, Almadrones L, Gilbert MR. Chemotherapy-induced peripheral neuropathy. Oncol Nurs Forum. 2005; 32(2): 305-11[DOI][PubMed]
  • 4. Gilchrist L. Chemotherapy-induced peripheral neuropathy in pediatric cancer patients. Semin Pediatr Neurol. 2012; 19(1): 9-17[DOI][PubMed]
  • 5. Cavaletti G, Bogliun G, Marzorati L, Tredici G, Colombo N, Parma G, et al. Long-term peripheral neurotoxicity of cisplatin in patients with successfully treated epithelial ovarian cancer. Anticancer Res. 1994; 14(3B): 1287-92[PubMed]
  • 6. Wolf S, Barton D, Kottschade L, Grothey A, Loprinzi C. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur J Cancer. 2008; 44(11): 1507-15[DOI][PubMed]
  • 7. Mileshkin L, Stark R, Day B, Seymour JF, Zeldis JB, Prince HM. Development of neuropathy in patients with myeloma treated with thalidomide: patterns of occurrence and the role of electrophysiologic monitoring. J Clin Oncol. 2006; 24(27): 4507-14[DOI][PubMed]
  • 8. Cardona AF, Ortiz LD, Reveiz L. Neuropatía inducida por el tratamiento médico del cáncer. Med UIS. 2010; 23(2): 103-27
  • 9. Argyriou AA, Bruna J, Marmiroli P, Cavaletti G. Chemotherapy-induced peripheral neurotoxicity (CIPN): an update. Crit Rev Oncol Hematol. 2012; 82(1): 51-77[DOI][PubMed]
  • 10. England JD, Gronseth GS, Franklin G, Miller RG, Asbury AK, Carter GT, et al. Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology. 2005; 64(2): 199-207[DOI][PubMed]
  • 11. Albers J, Chaudhry V, Cavaletti G, Donehower R. Interventions for preventing neuropathy caused by cisplatin and related compounds. Cochrane Database Syst Rev. 2007; (1)[DOI][PubMed]
  • 12. Gilchrist LS, Tanner L. The pediatric-modified total neuropathy score: a reliable and valid measure of chemotherapy-induced peripheral neuropathy in children with non-CNS cancers. Support Care Cancer. 2013; 21(3): 847-56[DOI][PubMed]
  • 13. Hislop HJ, Montgomery J. Daniels and Worthingham's Muscle Testing: Techniques of Manual Examination. 1995; : 2-6
  • 14. Ramchandren S, Leonard M, Mody RJ, Donohue JE, Moyer J, Hutchinson R, et al. Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia. J Peripher Nerv Syst. 2009; 14(3): 184-9[DOI][PubMed]
  • 15. Legha SS. Vincristine neurotoxicity. Pathophysiology and management. Med Toxicol. 1986; 1(6): 421-7[DOI][PubMed]
  • 16. Sandler SG, Tobin W, Henderson ES. Vincristine-induced neuropathy. A clinical study of fifty leukemic patients. Neurology. 1969; 19(4): 367-74[PubMed]
  • 17. Díaz-Jaimes E, Pe-aloza-Ochoa L, Parada-Onoko PM. Electrophysiological changes of peripheral neuropathy with vincristine after a physical therapy program in pediatric patients with acute lymphoblastic leukemia. Bol Med Hosp Infant Mex. 2009; 66(6): 529-36
  • 18. De Braganca KC, Packer RJ. Neurotoxicity of chemotherapeutic and biologic agents in children with cancer. Curr Neurol Neurosci Rep. 2008; 8(2): 114-22[PubMed]
  • 19. Openshaw H, Slatkin NE, Stein AS, Hinton DR, Forman SJ. Acute polyneuropathy after high dose cytosine arabinoside in patients with leukemia. Cancer. 1996; 78(9): 1899-905[PubMed]
  • 20. Martinez-Cayuelas E, Domingo-Jimenez R, Pascual-Gazquez JF, Martinez-Salcedo E, Alarcon-Martinez H, Bermudez-Cortes M, et al. [Neurological complications in the population of children with leukaemia]. Rev Neurol. 2015; 60(3): 108-14[PubMed]
  • 21. Vagace JM, de la Maya MD, Caceres-Marzal C, Gonzalez de Murillo S, Gervasini G. Central nervous system chemotoxicity during treatment of pediatric acute lymphoblastic leukemia/lymphoma. Crit Rev Oncol Hematol. 2012; 84(2): 274-86[DOI][PubMed]
  • 22. Lo Nigro L, Di Cataldo A, Schiliro G. Acute neurotoxicity in children with B-lineage acute lymphoblastic leukemia (B-ALL) treated with intermediate risk protocols. Med Pediatr Oncol. 2000; 35(5): 449-55[PubMed]
  • 23. Parasole R, Petruzziello F, Menna G, Mangione A, Cianciulli E, Buffardi S, et al. Central nervous system complications during treatment of acute lymphoblastic leukemia in a single pediatric institution. Leuk Lymphoma. 2010; 51(6): 1063-71[DOI][PubMed]
  • 24. Velasco R, Bruna J. [Chemotherapy-induced peripheral neuropathy: an unresolved issue]. Neurologia. 2010; 25(2): 116-31[DOI][PubMed]
  • 25. Lavoie Smith EM, Li L, Chiang C, Thomas K, Hutchinson RJ, Wells EM, et al. Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia. J Peripher Nerv Syst. 2015; 20(1): 37-46[DOI][PubMed]
  • 26. Perrot S, Le Jeunne C. [Steroid-induced myopathy]. Presse Med. 2012; 41(4): 422-6[DOI][PubMed]
  • 27. Farquhar-Smith P. Chemotherapy-induced neuropathic pain. Curr Opin Support Palliat Care. 2011; 5(1): 1-7[DOI][PubMed]
  • 28. Gilchrist LS, Marais L, Tanner L. Comparison of two chemotherapy-induced peripheral neuropathy measurement approaches in children. Support Care Cancer. 2014; 22(2): 359-66[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments